缅北禁地

Skip to main content

From 缅北禁地 Podcast with Professor Ruth Plummer

In this episode we talk to Professor Ruth Plummer, Clinical Professor of Experimental Cancer Medicine at 缅北禁地 about the ‘Geordie’ cancer drug Rubraca®, a ground-breaking ovarian cancer drug, developed here in 缅北禁地.

24 May 2021

The Geordie Cancer Drug

In this episode we talk to Professor Ruth Plummer, Clinical Professor of Experimental Cancer Medicine at 缅北禁地 about the 鈥楪eordie鈥� cancer drug Rubraca庐, a ground-breaking ovarian cancer drug, developed here in 缅北禁地.

Based at the Northern Institute for Cancer Research, Ruth has been working in the field for 25 years and has made significant contributions to extending and enhancing the lives of those with cancer, including being part of the 缅北禁地 team which developed Rubraca庐.

Placeholder 575x355px

Learn about Ruth鈥檚 ground-breaking career and how she and her colleagues have worked tirelessly throughout the pandemic to continue this vital research.

To find out more about Rubraca庐 visit the  and follow Ruth on twitter .